SE8804586L - 1,4-dihydro-4-oxonaftyridinderivat och salter daerav foerfarande foer framstaellning av dessa jaemte antibakteriella medel innefattande dessa - Google Patents

1,4-dihydro-4-oxonaftyridinderivat och salter daerav foerfarande foer framstaellning av dessa jaemte antibakteriella medel innefattande dessa

Info

Publication number
SE8804586L
SE8804586L SE8804586A SE8804586A SE8804586L SE 8804586 L SE8804586 L SE 8804586L SE 8804586 A SE8804586 A SE 8804586A SE 8804586 A SE8804586 A SE 8804586A SE 8804586 L SE8804586 L SE 8804586L
Authority
SE
Sweden
Prior art keywords
salts
antibacterial agents
oxonaftyridine
dihydro
procedures
Prior art date
Application number
SE8804586A
Other languages
English (en)
Other versions
SE8804586D0 (sv
SE501412C2 (sv
Inventor
H Narita
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13845280&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8804586(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of SE8804586L publication Critical patent/SE8804586L/sv
Publication of SE8804586D0 publication Critical patent/SE8804586D0/sv
Publication of SE501412C2 publication Critical patent/SE501412C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE8804586A 1984-04-26 1988-12-20 1,4-dihydro-4-oxonaftyridinderivat och salter därav förfarande för framställning av dessa jämte antibakteriella medel innefattande dessa SE501412C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59084963A JPS60228479A (ja) 1984-04-26 1984-04-26 １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩

Publications (3)

Publication Number Publication Date
SE8804586L true SE8804586L (sv) 1988-12-20
SE8804586D0 SE8804586D0 (sv) 1988-12-20
SE501412C2 SE501412C2 (sv) 1995-02-13

Family

ID=13845280

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8502017A SE463102B (sv) 1984-04-26 1985-04-25 1,4-dihydro-4-oxonaftyridinderivat och salter daerav, foerfarande foer framstaellning av dessa jaemte antibakteriella medel innefattande dessa
SE8804586A SE501412C2 (sv) 1984-04-26 1988-12-20 1,4-dihydro-4-oxonaftyridinderivat och salter därav förfarande för framställning av dessa jämte antibakteriella medel innefattande dessa

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE8502017A SE463102B (sv) 1984-04-26 1985-04-25 1,4-dihydro-4-oxonaftyridinderivat och salter daerav, foerfarande foer framstaellning av dessa jaemte antibakteriella medel innefattande dessa

Country Status (30)

Country Link
JP (1) JPS60228479A (sv)
KR (1) KR870001693B1 (sv)
AR (1) AR241911A1 (sv)
AT (2) AT389698B (sv)
AU (2) AU565087B2 (sv)
BE (1) BE902279A (sv)
CH (1) CH673458A5 (sv)
CS (1) CS250684B2 (sv)
DD (1) DD238795A5 (sv)
DE (2) DE3514076A1 (sv)
DK (1) DK165877C (sv)
EG (1) EG17339A (sv)
ES (2) ES8700256A1 (sv)
FI (1) FI80453C (sv)
FR (2) FR2563521B1 (sv)
GB (2) GB2158825B (sv)
HU (2) HU194226B (sv)
ID (1) ID21142A (sv)
IL (1) IL75021A (sv)
IT (1) IT1209953B (sv)
LU (1) LU85871A1 (sv)
NL (2) NL187314C (sv)
NO (1) NO162238C (sv)
NZ (1) NZ211895A (sv)
PH (3) PH22801A (sv)
PL (1) PL147392B1 (sv)
PT (1) PT80349B (sv)
RO (2) RO91871B (sv)
SE (2) SE463102B (sv)
ZA (1) ZA853102B (sv)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6172753A (ja) * 1984-09-18 1986-04-14 Dainippon Pharmaceut Co Ltd ピリジルケトン誘導体
AT392789B (de) 1985-01-23 1991-06-10 Toyama Chemical Co Ltd Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester
IL79189A (en) * 1985-06-26 1990-07-12 Daiichi Seiyaku Co Quinoline and/or naphthyridine-4-oxo-3-carboxylic acid derivatives,process for their preparation and pharmaceutical compositions comprising them
IE62600B1 (en) * 1987-08-04 1995-02-22 Abbott Lab Naphtyridine antianaerobic compounds
US4962112A (en) * 1987-08-04 1990-10-09 Abbott Laboratories 7-(2-methyl-4-aminopyrrolidinyl)naphthryidine and quinoline compounds
US4859776A (en) * 1988-03-11 1989-08-22 Abbott Laboratories (S)-7-(3-aminopyrrolidin-1-yl)-1-(ortho, para-difluorophenyl)-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid and method for its preparation
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
DE3934082A1 (de) * 1989-10-12 1991-04-18 Bayer Ag Chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung als antivirale mittel
EP0571400A1 (en) * 1991-01-14 1993-12-01 Hanmi Pharmaceutical Co.,Ltd. Novel quinolone compounds and processes for preparation thereof
FR2692577B1 (fr) * 1992-05-26 1996-02-02 Bouchara Sa Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
KR940014395A (ko) * 1992-12-09 1994-07-18 강박광 신규한 퀴놀론 유도체 및 그의 제조방법
KR0148277B1 (ko) * 1993-01-18 1998-11-02 채영복 신규한 플루오르퀴놀론계 유도체 및 그의 제조방법
AU4272793A (en) * 1993-04-24 1994-11-21 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and process for preparing the same
KR950018003A (ko) * 1993-12-09 1995-07-22 스미스클라인 비참 피엘씨 신규한 퀴놀론 유도체 및 그의 제조 방법
EP0787720B1 (en) * 1994-10-20 2003-07-16 Wakunaga Seiyaku Kabushiki Kaisha Pyridonecarboxylate derivative or salt thereof and antibacterial containing the same as active ingredient
US6211375B1 (en) 1996-04-19 2001-04-03 Wakunaga Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents containing the same as the active ingredient
CA2269984A1 (en) * 1996-10-30 1998-05-07 Bayer Aktiengesellschaft Method or producing naphthyridine compounds and novel intermediate products
DE19713506A1 (de) 1997-04-01 1998-10-08 Bayer Ag Verfahren zur Herstellung von 2,6-Dichlor-5-fluornicotinonitril und die chemische Verbindung 3-Cyano-2-hydroxy-5-fluorpyrid-6-on-mononatriumsalz sowie dessen Tautomere
WO2000054811A1 (fr) 1999-03-17 2000-09-21 Daiichi Pharmaceutical Co., Ltd. Compositions medicamenteuses
DE19926400A1 (de) 1999-06-10 2000-12-14 Bayer Ag Verbessertes Verfahren zur Herstellung von 2,6-Dichlor-5-fluor-nicotinsäure und grobteilige und besonders reine 2,6-Dichlor-5-fluor-nicotinsäure
WO2001017991A1 (fr) 1999-09-02 2001-03-15 Wakunaga Pharmaceutical Co., Ltd. Derive d'acide quinolinecarboxylique ou son sel
AU2001286852A1 (en) * 2000-08-29 2002-03-13 Chiron Corporation Quinoline antibacterial compounds and methods of use thereof
KR100981351B1 (ko) * 2003-10-29 2010-09-10 주식회사 엘지생명과학 7-클로로-1-사이클로프로필-6-플루오로-4-옥소-1,4-디하이드로-1,8-나프티리딘-3-카복실산의 제조방법
CN101792443A (zh) * 2010-03-09 2010-08-04 北京欧凯纳斯科技有限公司 氟代喹诺酮衍生物及其制备方法和用途
JOP20190045A1 (ar) 2016-09-14 2019-03-14 Bayer Ag مركبات أميد حمض 1- أريل-نفثيريدين-3-كربوكسيليك مستبدلة في الموضع 7 واستخدامها.
CN114369092A (zh) * 2021-12-20 2022-04-19 赤峰万泽药业股份有限公司 甲苯磺酸妥舒沙星及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2125310A1 (en) * 1971-05-21 1972-11-30 Sterling Drug Inc , New York, NY (V St A) 1-alkyl-1,4-dihydro-4-oxo-1,8-naphtyridine 3-carboxylic acids antibac
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4382937A (en) 1981-02-27 1983-05-10 Dainippon Pharmaceutical Co., Ltd. Naphthyridine derivatives and their use as anti-bacterials
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
NZ210847A (en) * 1984-01-26 1988-02-29 Abbott Lab Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions
IL74064A (en) * 1984-01-26 1988-09-30 Abbott Lab 1,7-disubstituted-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives and antibacterial compositions containing them
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester

Also Published As

Publication number Publication date
GB8510297D0 (en) 1985-05-30
AU4165085A (en) 1985-10-31
KR870001693B1 (ko) 1987-09-24
KR850007596A (ko) 1985-12-07
FI851637L (fi) 1985-10-27
SE8502017L (sv) 1985-10-27
NO851643L (no) 1985-10-28
FR2563521A1 (fr) 1985-10-31
FI80453B (fi) 1990-02-28
PL147392B1 (en) 1989-05-31
DE3514076A1 (de) 1985-10-31
EG17339A (en) 1989-06-30
ATA122485A (de) 1989-06-15
HUT38634A (en) 1986-06-30
DK185685A (da) 1985-10-27
PH22801A (en) 1988-12-12
PT80349A (en) 1985-05-01
GB2191776B (en) 1990-03-28
RO91871B (ro) 1987-07-31
SE8804586D0 (sv) 1988-12-20
CH673458A5 (sv) 1990-03-15
AU565087B2 (en) 1987-09-03
AU8180487A (en) 1988-03-24
IT1209953B (it) 1989-08-30
SE463102B (sv) 1990-10-08
ES8706673A1 (es) 1987-07-01
GB2191776A (en) 1987-12-23
IL75021A0 (en) 1985-08-30
RO95509B (ro) 1988-10-01
PL253108A1 (en) 1985-12-17
DD238795A5 (de) 1986-09-03
FI851637A0 (fi) 1985-04-25
AT389698B (de) 1990-01-10
DE3546658C2 (sv) 1992-04-02
AT390258B (de) 1990-04-10
IT8548002A0 (it) 1985-04-26
BE902279A (fr) 1985-10-25
RO91871A (ro) 1987-07-30
ES551538A0 (es) 1987-07-01
ATA267888A (de) 1989-09-15
ES8700256A1 (es) 1986-09-16
AR241911A1 (es) 1993-01-29
FR2614620B1 (fr) 1990-03-09
FR2614620A1 (fr) 1988-11-04
DE3514076C2 (sv) 1989-03-30
IL75021A (en) 1994-01-25
GB8716897D0 (en) 1987-08-26
AU612993B2 (en) 1991-07-25
JPS60228479A (ja) 1985-11-13
NL8501172A (nl) 1985-11-18
ZA853102B (en) 1986-12-30
FR2563521B1 (fr) 1989-02-03
DK165877C (da) 1993-06-21
PH25046A (en) 1991-01-28
FI80453C (sv) 1990-06-11
SE501412C2 (sv) 1995-02-13
HU197571B (en) 1989-04-28
HU194226B (en) 1988-01-28
CS250684B2 (en) 1987-05-14
ES542584A0 (es) 1986-09-16
SE8502017D0 (sv) 1985-04-25
RO95509A (ro) 1988-09-30
JPS6320828B2 (sv) 1988-04-30
PH25228A (en) 1991-03-27
NL187314C (nl) 1991-08-16
NZ211895A (en) 1988-07-28
LU85871A1 (en) 1985-12-16
DK165877B (da) 1993-02-01
NL9100648A (nl) 1991-08-01
NO162238B (no) 1989-08-21
GB2158825A (en) 1985-11-20
ID21142A (id) 1999-04-29
GB2158825B (en) 1989-01-25
NO162238C (no) 1989-12-06
PT80349B (pt) 1987-09-30
DK185685D0 (da) 1985-04-25

Similar Documents

Publication Publication Date Title
SE8804586D0 (sv) 1,4-dihydro-4-oxonaftyridinderivat och salter daerav foerfarande foer framstaellning av dessa jaemte antibakteriella medel innefattande dessa
NO921835D0 (no) Fremgangsmaate for fremstilling av amidinofenylalaninderivat samt anvendelse derav
SE7714592L (sv) Cyklopentan-1-aminer, forfarande for framstellning derav och medel innehallande dessa foreningar
NZ217650A (en) Quinoline derivatives and pharmaceutical compositions
NO952743D0 (no) Ny benzotiadiazinforbindelse, dens fremstilling og farmasöytiske preparater
DE3673688D1 (de) Succinimide derivate, herstellung und anwendung.
ES497064A0 (es) Un procedimiento para la preparacion de indolo benzoxazinas.
SE8502525L (sv) 1,3-oxazolidin-2-on-derivat och forfaranden for framstellning derav
FI863565A (fi) Foerfarande foer framstaellning av nya pyrrobenzimidazoler, pyrrolbenzoxazoler och pyrrolbenztiazoler.
ES545717A0 (es) Procedimiento para preparar derivados de flaveno y tioflave-no
NO873353D0 (no) Fremgangsmaate for fremstilling av antibakterielle 7-okso-4-tia-1-azabicyklo(3.2.0)hept-2-en-derivater.
IT1241927B (it) 3'-deamino-4'-deossi-4'-amino-8-fluoroantra- cicline processi per la loro preparazione e composizioni farmaceutiche che le contengono
ES538155A0 (es) Procedimiento para la obtencion de un derivado de arganofosfato
ES550817A0 (es) Procedimiento para preparar derivados de n-carboxialquil-2--oxo-3-diaril-5,6-triazinas
DK601883D0 (da) Phenyl-propanolderivater
ES515201A0 (es) "procedimiento para la fabricacion de derivados n- susbtituidos de la tetrahidroisftalimida".
DK158736C (da) 1,3-dihydro-6-aminomethyl-7-hydroxy-furo-(3,4-c)-pyridin-derivater samt terapeutisk praeparat indeholdende saadanne forbindelse
SE8002937L (sv) Nytt n,n'-difenylhydrazinderivat och forfarande for framstellning derav
JPS53119825A (en) 1,3-dithioallophanate derivatives, their preparation, insecticides, acaricides, and bactericides for agricultural and horticultural uses
NO172492C (no) Fremgangsmaate for fremstilling av alkalimetall- eller jordalkalimetallsalter av n5-formyl-5,6,7,8-tetrahydrofolsyre

Legal Events

Date Code Title Description
NUG Patent has lapsed